Eating betterwhile preserving muscle mass and metabolic healthstill requires strategy
Other Types of Agonists in MASH Clinical Trials Glucagon-GLP-1 Dual Agonists Survodutide is a dual agonist that targets both GLP-1 and glucagon receptors
BPC-157 also interacts with the dopaminergic, serotonergic, and GABAergic systems in the CNS, where its shown anxiolytic and neuroprotective effects in rodent behavioural models
Unlike GLP-1 medications, its effects are not fast-acting and havent been studied long-term in large groups
Especially areas with wrinkles, such as face, neck, under the eyes, arm, wrist, etc
If you're on injection and still not responding, your prescribing clinician may consider a switch from semaglutide to tirzepatide or a dual-compound approach like GLP-Squared